Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

546 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
[Does erythropoietin treatment influence the lipid status of patients on maintenance hemodialysis?].
Król E, Debska-Slizień A, Biedunkiewicz B, Zdrojewski Z, Wróblewska M, Rutkowski B. Król E, et al. Among authors: Rutkowski B. Pol Arch Med Wewn. 1995 Nov;94(5):410-7. Pol Arch Med Wewn. 1995. PMID: 8833938 Polish.
The aim of the present study was to measure changes in serum lipid concentration in two comparable groups: I--11 patients (7f, 4m) aged 47 +/- 8 years receiving r-Epo s.c. during at least 6 months before HD and 2 years of HD with initial dose 3 x 50 u/kg b.w. and II--18 patients (7f, 11m) aged 45 +/- 8 years without r-Epo in that period of time. Following parameters were estimated every two months: total cholesterol (CH-C), HDL cholesterol (HDL-CH), LDL cholesterol (LDL-CH), triglycerides (TG), apolipoprotein B (Apo B). ...
The aim of the present study was to measure changes in serum lipid concentration in two comparable groups: I--11 patients (7f, 4m) aged 47 + …
[Acquired cysts of the kidney in patients treated with long-term dialysis].
Spineter-Sokołowska E, Liberek T, Brylowska A, Potaz Z, Sokół A, Rutkowski B. Spineter-Sokołowska E, et al. Among authors: Rutkowski B. Pol Arch Med Wewn. 1994 Sep;92(3):243-50. Pol Arch Med Wewn. 1994. PMID: 7808934 Polish.
[Effect of treatment with erythropoietin (r-EPO) on hemodynamics of the cardiovascular system in patients with chronic renal failure (c.r.f.)].
Kubasik A, Debska-Slizień A, Dudziak M, Bułło B, Rutkowski B. Kubasik A, et al. Among authors: Rutkowski B. Pol Arch Med Wewn. 1994 Sep;92(3):217-22. Pol Arch Med Wewn. 1994. PMID: 7808930 Polish.
The I group was given initial dose 3 x 2000 u per week (mean dose 24-46 u/kg b.w./per week, the II was on 3 x 2000 u per week (mean dose 24-46 u/kg b.w....
The I group was given initial dose 3 x 2000 u per week (mean dose 24-46 u/kg b.w./per week, the II was on 3 x 2000 u per week (mean d …
[Some clinical aspects of erythropoietin action used at doses not affecting erythropoiesis in hemodialysed patients].
Szołkiewicz M, Manitius J, Kopecka L, Jakubowski Z, Lysiak-Szydłowska WA, Rutkowski B. Szołkiewicz M, et al. Among authors: Rutkowski B. Pol Arch Med Wewn. 1994;92 Spec No:78-84. Pol Arch Med Wewn. 1994. PMID: 7731903 Polish.
The aim of presented study was to evaluate the biochemical and clinical effects of using erythropoietin at doses not influence hemopoiesis. 10 hemodialysis patients with stable hemoglobin and hematocrit levels, were given erythropoietin at dose of 7-10U/kg.b.w....
The aim of presented study was to evaluate the biochemical and clinical effects of using erythropoietin at doses not influence hemopoiesis. …
546 results
Jump to page
Feedback